Useful resources |
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients (Cochrane Review) ABSTRACT Background: Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD). Standard protocols in use typically involve three drug groups each directed to a site in the T-cell activation or proliferation cascade which are . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |